MedTrace Logo

The DIEP Flap as a Model of Ischemia-Reperfusion: an Intervention Study

NCT00821158 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-01-13

No results posted yet for this study

Summary

The investigators will examine whether administration of certain medications will decrease or prevent ischemia-reperfusion injury.

Conditions

  • Ischemia-Reperfusion

Interventions

DRUG

Antioxidant

Antioxidant iv bolus

OTHER

Placebo

Placebo tablet and iv

DRUG

Anti-inflammatory drug

Anti-inflammatory tablet

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • R. van der Hulst, M.D., Phd · Maastricht Universtity Medical Center

  • Marieke van den Heuvel, M.D. · Maastricht University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00821158 on ClinicalTrials.gov